Immunosuppression-induced bronchial epithelial-mesenchymal transition: A potential contributor to obliterative bronchiolitis

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 2, 2011, Pages 523-530

  Felton, Valerie M ^a   Inge, Landon J ^a   Willis, Brigham C ^a   Bremner, Ross M ^a   Smith, Michael A ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLLAGEN; CYCLOSPORIN; FIBRONECTIN; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHUS MUCOSA; CELL ADHESION; CELL LINE; CELL MEMBRANE; CELL SHAPE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; EPITHELIUM CELL; EXTRACELLULAR MATRIX; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYME CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BIOLOGICAL MARKERS; BRONCHI; BRONCHIOLITIS OBLITERANS; CADHERINS; CELL ADHESION; CELL LINE; CELL SHAPE; COLLAGEN; CYTOSKELETON; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; RATS; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

EID: 78751584930     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.10.006     Document Type: Article

References (28)

1. G.J. Berry, E.M. Brunt, D. Chamberlain, R.H. Hruban, R.K. Sibley, and S. Stewart A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation J Heart Transplant 9 1990 593 601
2. A. Boehler, S. Kesten, W. Weder, and R. Speich Bronchiolitis obliterans after lung transplantation: a review Chest 114 1998 1411 1426
3. P.F. Halloran, J. Homik, N. Goes, S.L. Lui, J. Urmson, and V. Ramassar The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes Transplant Proc 29 1997 79 81
4. S.G. Tullius, and N.L. Tilney Both alloantigen-dependent and -independent factors influence chronic allograft rejection Transplantation 59 1995 313 318
5. M.W. Epperly, H. Guo, J.E. Gretton, and J.S. Greenberger Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis Am J Respir Cell Mol Biol 29 2003 213 224
6. W. Schurch, T.A. Seemayer, and G. Gabbiani The myofibroblast: a quarter century after its discovery Am J Surg Pathol 22 1998 141 147
7. B.C. Willis, and Z. Borok TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease Am J Physiol Lung Cell Mol Physiol 293 2007 L525 L534
8. L.A. Borthwick, S.M. Parker, K.A. Brougham, G.E. Johnson, M.R. Gorowiec, and C. Ward Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation Thorax 64 2009 770 777
9. A. El-Gamel, E. Sim, P. Hasleton, J. Hutchinson, N. Yonan, and J. Egan Transforming growth factor β (TGF-β) and obliterative bronchiolitis following pulmonary transplantation J Heart Lung Transplant 18 1999 828 837
10. S. Hodge, M. Holmes, B. Banerjee, M. Musk, A. Kicic, and G. Waterer Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition Am J Transplant 9 2009 727 733
11. C. Slattery, E. Campbell, T. McMorrow, and M.P. Ryan Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition Am J Pathol 167 2005 395 407
12. P.E. Roberts, D.M. Phillips, and J.P. Mather A novel epithelial cell from neonatal rat lung: isolation and differentiated phenotype Am J Physiol 259 6 Pt 1 1990 L415 L425
13. C. Monchaud, and P. Marquet Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II Clin Pharmacokinet 48 2009 489 516
14. S. Masuda, and K. Inui An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients Pharmacol Ther 112 2006 184 198
15. F.G. Fernández, A. Jaramillo, C. Chen, D.Z. Liu, T. Tung, and G.A. Patterson Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease Am J Transplant 4 2004 319 325
16. C. Ward, I.A. Forrest, D.M. Murphy, G.E. Johnson, H. Robertson, and T.E. Cawston Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients Thorax 60 2005 865 871
17. P.J. Sime, and K.M. O'Reilly Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment Clin Immunol 99 2001 308 319
18. B.C. Willis, R.M. duBois, and Z. Borok Epithelial origin of myofibroblasts during fibrosis in the lung Proc Am Thorac Soc 3 2006 377 382
19. A. Bergeron, P. Soler, M. Kambouchner, P. Loiseau, B. Milleron, and D. Valeyre Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-β and IL-10 Eur Respir J 22 2003 69 76
20. A.M. Ramirez, Z. Shen, J.D. Ritzenthaler, and J. Roman Myofibroblast transdifferentiation in obliterative bronchiolitis: TGF-β signaling through smad3-dependent and -independent pathways Am J Transplant 6 2006 2080 2088
21. B.D. Myers, J. Ross, L. Newton, J. Luetscher, and M. Perlroth Cyclosporine-associated chronic nephropathy N Engl J Med 311 1984 699 705
22. D.W. Johnson, H.J. Saunders, F.J. Johnson, S.O. Huq, M.J. Field, and C.A. Pollock Fibrogenic effects of cyclosporin A on the tubulointerstitium: role of cytokines and growth factors Exp Nephrol 7 1999 470 478
23. R.J. Keenan, H. Konishi, A. Kawai, I.L. Paradis, D.R. Nunley, and A.T. Iacono Clinical trial of tacrolimus versus cyclosporine in lung transplantation Ann Thorac Surg 60 1995 580 585
24. J.G. Zhang, M.W. Walmsley, J.V. Moy, A.C. Cunningham, D. Talbot, and J.H. Dark Differential effects of cyclosporin A and tacrolimus on the production of TGF-β: implications for the development of obliterative bronchiolitis after lung transplantation Transpl Int 11 Suppl. 1 1998 S325 S327
25. R. Speich, S. Schneider, M. Hofer, S. Irani, P. Vogt, and W. Weder Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation Pulm Pharmacol Ther 23 5 2010 445 449
26. G.L. Gupte, S. Mahadevan, J.R. Clarke, H. Alton, and S.V. Beath Sirolimus-related pulmonary toxicity mimicking 'asthma like' symptoms World J Gastroenterol 13 2007 5151 5153
27. L.M. Crosby, and C.M. Waters Epithelial repair mechanisms in the lung Am J Physiol Lung Cell Mol Physiol 298 2010 L715 L731
28. B.C. Willis, J.M. Liebler, K. Luby-Phelps, A.G. Nicholson, E.D. Crandall, and R.M. du Bois Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis Am J Pathol 166 2005 1321 1332